TABLE 4.
Cardiometabolic outcomes at 6- and 12-month follow-ups for each interventiona
| Between-groups difference | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
| Baseline | 6 months | 12 months | 6 months | 12 months | ||||||||
|
|
|
|
|
|
||||||||
| Outcome | M | SD | M | SD | M | SD | t | df | p | t | df | p |
|
| ||||||||||||
| Systolic blood pressure | .97 | 121 | .33 | −.02 | 93 | .98 | ||||||
| PeerFIT | 115.1 | 12.8 | 115.9 | 13.4 | 114.2 | 13.3 | ||||||
| BEAT | 116.4 | 15.1 | 115.7 | 12.1 | 115.6 | 13.1 | ||||||
| Diastolic blood pressure | 2.20 | 122 | .03 | −.03 | 96 | .98 | ||||||
| PeerFIT | 77.6 | 8.4 | 79.9 | 9.9 | 77.3 | 10.6 | ||||||
| BEAT | 78.8 | 10.8 | 77.7 | 9.8 | 77.3 | 10.6 | ||||||
| Total cholesterol (mg/dL) | −.67 | 113 | .50 | −.885 | 86 | .38 | ||||||
| PeerFIT | 166.0 | 41.8 | 164.5 | 40.4 | 163.2 | 39.8 | ||||||
| BEAT | 174.2 | 45.9 | 171.1 | 41.3 | 172.8 | 54.1 | ||||||
| Low-density lipoprotein (mg/dL) | −1.9 | 102 | .06 | −.72 | 73 | .47 | ||||||
| PeerFIT | 94.0 | 32.3 | 88.9 | 25.8 | 92.7 | 27.4 | ||||||
| BEAT | 97.5 | 35.6 | 99.9 | 36.1 | 97.1 | 46.6 | ||||||
| High-density lipoprotein (mg/dL) | .716 | 115 | .48 | −.95 | 86 | .34 | ||||||
| PeerFIT | 47.1 | 18.1 | 44.1 | 12.2 | 43.9 | 11.2 | ||||||
| BEAT | 42.6 | 13.5 | 41.6 | 9.3 | 43.3 | 11.8 | ||||||
| Hemoglobin A1c (%) | −.05 | 113 | .96 | .22 | 87 | .83 | ||||||
| PeerFIT | 5.3 | .8 | 5.3 | .7 | 5.6 | 1.4 | ||||||
| BEAT | 5.3 | 1.0 | 5.3 | .6 | 5.5 | .7 | ||||||
a
BEAT, basic education supported by activity tracking.